Zdrowie i gospodarka · 29/04/2015
FDA Releases Draft Guidance on Environmental Assessments for Drugs with Estrogenic, Androgenic, or Thyroid Activity
The FDA has published a draft guidance to help pharmaceutical companies determine if their new drugs or supplements require environmental assessments, and what information to include in such assessments
Original source language: Federal Register — Food and Drug AdministrationOpen original release →